OKKO Masterclass 360: What's New in 2023?
Date: 26/03/2023 (AEST)
Venue: Brisbane Convention & Exhibition Centre, Cnr Merivale and Glenelg Streets, South Bank, Brisbane, QLD, 4000
Provider: OKKO Eye Specialist Centre
Contact: Jessica Bock, [E] info@masterclass360.com.au, [P] 07 37250222
Learning Objectives
- Review a range of lesions presenting in the anterior and posterior segment, as well as on clinical imaging
- Review clinical and diagnostic investigations that can be used to differentiate lesions
- Review appropriate management of various lesions
- Understand the range of presentations that affect the anterior segment
- Discuss diagnostic & treatment algorithms that are needed for safe, high-quality outcomes for patients
- Gain insight into how different specialists might approach similar disease presentations
- Gain a better understanding of how to best co-manage Open Angle Glaucoma patients and timing of their referrals
- Understand optimal management of Primary Angle Closure Disease patients, including the application of the ZAP study
- Gain a broader knowledge how to co-manage some of the Secondary Glaucoma patients
- To review optometric management of common medical & refractive conditions following cataract surgery
- To provide an overview of the appropriate management of each of these conditions including therapeutic medical management
- To enable the identification of postop complications requiring urgent referral for specialist care
- To review the current approach to the management of neovascular AMD
- To review new drug treatments for neovascular AMD (Beovu & Vabysmo)
- To provide an overview of novel treatments that are expected to impact the management of neovascular and dry AMD within 5 years
- When to prescribe glasses (and when not to) in children
- When to refer to a pediatric ophthalmologist
- To identify common benign skin eyelid lesions and their management
- To identify common malignant skin eyelid lesions and their management
- Tips to differentiate common eyelid lesions and when to refer to a specialist
- Gain insight into cataract surgery and navigating it's challenges in a third-world country
- Form a differential for diagnosing lesions of the peripheral cornea and limbus including ocular surface cancer
- Know when to refer for conditions affecting the limbus
- Institute management strategies to support limbal stem cells and corneal health
- Take a deeper delve into the latest diagnostic challenges, clinical diagnostic work up and diagnostic devices and therapeutic/medical, laser and surgical management of current clinical topics topics and controversies in cataract,/refractive, glaucoma, complex anterior segment, macula and vitreoretinal disease.
Max CPD hours awarded: 7.5
Session Information
| Name |
|---|
| Lots of Little & Large Lid Lesions |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| All That Goes Bump In The Eye |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| Refractive Errors in Childhood |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| An algorithm to Glaucoma Co-management |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| Eyes For Africa |
| Clinical? |
|---|
| No |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name |
|---|
| Recent and Future Advances in The Management of Age-Related Macular Degeneration |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.5 |
| Name |
|---|
| Limbal disease: Limbal stem cell failure, pterygium and ocular surface neoplasia - Picking serious from benign |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| OKKO Q & A Panel |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.75 |
| Name |
|---|
| The Optometrist's Survival Guide to Post-Op Cataract Surgery Problems |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name |
|---|
| Get a Second Opinion |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| No |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 1 |
| Name | Clinical? | Interactive? | Therapeutic? | CPD Hours |
|---|
| Lots of Little & Large Lid Lesions | Yes | No | Yes | 0.75 | 0.75 |
| All That Goes Bump In The Eye | Yes | No | Yes | 0.75 | 0.75 |
| Refractive Errors in Childhood | Yes | No | No | 0.75 | 0.75 |
| An algorithm to Glaucoma Co-management | Yes | No | Yes | 0.75 | 0.75 |
| Eyes For Africa | No | No | No | 0.5 | 0.5 |
| Recent and Future Advances in The Management of Age-Related Macular Degeneration | Yes | No | Yes | 0.5 | 0.5 |
| Limbal disease: Limbal stem cell failure, pterygium and ocular surface neoplasia - Picking serious from benign | Yes | No | Yes | 0.75 | 0.75 |
| OKKO Q & A Panel | Yes | No | Yes | 0.75 | 0.75 |
| The Optometrist's Survival Guide to Post-Op Cataract Surgery Problems | Yes | No | Yes | 1 | 1 |
| Get a Second Opinion | Yes | No | Yes | 1 | 1 |